Regencell Bioscience shares surge 26.06% after-hours driven by growing investor interest and confidence in potential.

Regencell Bioscience surged 26.06% in after-hours trading following a significant price jump reported earlier, with shares rising 23.7% to $16.09. The move reflects growing investor interest and confidence in the company's potential, particularly its focus on traditional Chinese medicine for neurocognitive disorders. Despite challenges in profitability and earnings quality, the stock's strong upward momentum has attracted market attention, highlighting optimism around its long-term prospects in the healthcare sector.